{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:11:45Z","timestamp":1790734305660,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/ico.0b013e31819e34cb","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T08:36:50Z","timestamp":1253263010000},"page":"1055-1060","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of Besifloxacin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Keratitis"],"prefix":"10.1097","volume":"28","author":[{"given":"Melissa E","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin W","family":"Norcross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quincy C","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210227","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0161-6420(00)00179-2","article-title":"Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.","volume":"107","author":"Alexandrakis","year":"2000","journal-title":"Ophthalmology"},{"key":"R2-19-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00003226-198906000-00007","article-title":"Factors influencing predilection and outcome in bacterial keratitis.","volume":"8","author":"Gudmundsson","year":"1989","journal-title":"Cornea"},{"key":"R3-19-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.icl.0000234002.88643.d0","article-title":"Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas.","volume":"33","author":"Pachigolla","year":"2007","journal-title":"Eye Contact Lens"},{"key":"R4-19-20210227","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajo.2007.03.032","article-title":"Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus.","volume":"144","author":"Freidlin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R5-19-20210227","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.eye.6701465","article-title":"External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA).","volume":"19","author":"Shanmuganathan","year":"2005","journal-title":"Eye"},{"key":"R6-19-20210227","first-page":"354","article-title":"A retrospective analysis of infection after corneal transplantation.","volume":"108","author":"Wakimasu","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"R7-19-20210227","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajo.2003.10.026","article-title":"Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R8-19-20210227","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0161-6420(01)00724-2","article-title":"An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.","volume":"108","author":"Kowalski","year":"2001","journal-title":"Ophthalmology"},{"key":"R9-19-20210227","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.48.6.1948-1952.2004","article-title":"Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.","volume":"48","author":"Dajcs","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-19-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcrs.2005.12.108","article-title":"Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.","volume":"32","author":"Moshirfar","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R11-19-20210227","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1167\/iovs.07-0320","article-title":"Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.","volume":"48","author":"OCallaghan","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-19-20210227","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3109\/02713689008997584","article-title":"The role of pneumolysin in ocular infections with Streptococcus pneumoniae.","volume":"9","author":"Johnson","year":"1990","journal-title":"Curr Eye Res"},{"key":"R14-19-20210227","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/02713680802478704","article-title":"Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.","volume":"33","author":"Zhang","year":"2008","journal-title":"Curr Eye Res"},{"key":"R15-19-20210227","first-page":"3017","article-title":"Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.","volume":"33","author":"Callegan","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-19-20210227","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.85.7.842","article-title":"Bacterial keratitis: a prospective clinical and microbiological study.","volume":"85","author":"Schaefer","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R17-19-20210227","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1128\/IAI.68.10.6052-6055.2000","article-title":"Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.","volume":"68","author":"Hume","year":"2000","journal-title":"Infect Immun"},{"key":"R18-19-20210227","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/IAI.62.6.2478-2482.1994","article-title":"Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.","volume":"62","author":"Callegan","year":"1994","journal-title":"Infect Immun"},{"key":"R20-19-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8093647","article-title":"Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus.","volume":"259","author":"Kreiswirth","year":"1993","journal-title":"Science"},{"key":"R21-19-20210227","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","article-title":"A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus.","volume":"44","author":"Katayama","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-19-20210227","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM198905043201806","article-title":"Methicillin-resistant Staphylococcus aureus.","volume":"320","author":"Brumfitt","year":"1989","journal-title":"N Engl J Med"},{"key":"R23-19-20210227","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.35.12.2562","article-title":"Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.","volume":"35","author":"Nakanishi","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-19-20210227","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.43.5.1129","article-title":"Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.","volume":"43","author":"Pan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-19-20210227","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.33.4.593","article-title":"Widespread quinolone-resistant Staphylococcus aureus isolates in a general hospital.","volume":"33","author":"Shalt","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-19-20210227","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.34.11.2050","article-title":"Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.","volume":"34","author":"Raviglione","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"R27-19-20210227","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/clinids\/24.Supplement_1.S67","article-title":"Trends in bacterial resistance to fluoroquinolones.","volume":"24","author":"Acar","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R28-19-20210227","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among Gram-positive cocci.","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"R29-19-20210227","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/514923","article-title":"Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.","volume":"27","author":"Hooper","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R30-19-20210227","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jop.2006.0137","article-title":"Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use.","volume":"23","author":"Ward","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"R31-19-20210227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/dkm398","article-title":"Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes.","volume":"61","author":"Zhang","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R32-19-20210227","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4269\/ajtmh.1992.46.552","article-title":"The natural history of endemic trachoma: a longitudinal study.","volume":"46","author":"Taylor","year":"1992","journal-title":"Am J Trop Med Hyg"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200910000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:33Z","timestamp":1786039173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200910000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31819e34cb","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}